Please login to the form below

enadenotucirev

This page shows the latest enadenotucirev news and features for those working in and with pharma, biotech and healthcare.

Bristol-Myers Squibb acquires Cormorant for $520m

That project will look at the safety and efficacy of enadenotucirev - which is made by PsiOxus Therapeutics in Oxford, UK - in combination with Opdivo for the treatment of a range of

Latest news

BMS to explore new options for its immuno-oncology drug Opdivo

Enadenotucirev is designed to have immune stimulating effects and the companies hope that combining it with Opdivo, which alleviates immune suppression, will improve tumour shrinkage and treatment durability. ... BMS has then reserved the rights to first

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Manager (PR): Great Benefits

Digital Associate Director - Medcomms: £65000 - £80000 per annum

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Experienced medical editor: Competitive salary and bonus scheme

Account Director: £Competitive Salary

Senior Medical Writer or Lead Medical Writer: £Competitive Salary

Brand Manager - Medium Global Pharma Company: £Competitive Financial Package

Group Director of Medical Affairs and Scientific Strategy, Medic...: Substantial six figure package

Account Director, Healthcare Communications: Salary TBC

Senior Medical Writer, MedComms Agency: Salary TBC

Scientific Director: £60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more

Account director: Competitive salary and bonus scheme

Account Director, Medical Education: Salary TBC

Senior External Communications Lead: £Competitive Salary

Account Manager: £Competitive Salary

Publications director: Competitive salary and bonus scheme

Subscribe to our email news alerts

PMHub

Add my company

Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

Novo Nordisk awakens its ‘Sleeping Beauty’: Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?: Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019: OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...